Adipose tissue-derived microvascular fragments (ad-MVF) represent effective vascularisation units for the seeding of dermal substitutes. However, particularly in case of extensive skin defects, the required amounts of donor fat tissue for the harvesting of ad-MVF may not always be available. Therefore, we herein determined the lowest ad-MVF density needed to induce a sufficient vascularisation and incorporation of seeded implants. Collagen-glycosaminoglycan matrices (Integra ® ; diameter: 4 mm) were seeded with 15,000 (HD), 10,000 (MD) and 5,000 (LD) ad-MVF and implanted into full-thickness skin defects within mouse dorsal skinfold chambers, to analyse their in vivo vascularisation and incorporation. Intravital fluorescence microscopy showed a comparable vascularisation of HD and MD ad-MVF-seeded Integra ® , which was significantly higher when compared to LD ad-MVF-seeded Integra ® . As assessed by photoacoustic imaging, this was associated with an increased oxygenation of the implants. Additional histological and immunohistochemical analyses revealed an enhanced cellular infiltration, collagen content, microvessel density and epithelialisation of HD and MD ad-MVF-seeded Integra ® , indicating a better incorporation compared to LD ad-MVF-seeded implants. These findings demonstrate that 80,000 ad-MVF/cm² is the least required density to guarantee an effective vascularisation of the dermal substitute.
Introduction
For the treatment of extensive skin defects, autologous split-thickness skin grafting (STSG) is the method of choice (Kneilling et al., 2011; Kanapathy et al., 2016) . However, particularly deep burn wounds, that exceed 50-60 % of the total body surface, bear the risk of extensive scarring and donor site shortage for skin transplantation (MacNeil, 2007; Böttcher-Haberzeth et al., 2010; Shevchenko et al., 2010; Miyanaga et al., 2016) . Moreover, the destruction of dermal and subcutaneous layers in deep wounds complicates the initial application of STSG and increases the risk of infection due to the loss of the skin's physiological barrier function.
To overcome these problems, several acellular matrices, such as Dermagraft ® (Organogenesis Inc.) or Integra ® (Integra Life Sciences), have been bioengineered as off-the-shelf products for the initial coverage of extensive dermal defects (Zhong et al., 2010; Graham et al., 2013; Debels et al., 2015; Singer et al., 2015) . As these dermal substitutes degrade over time, their porous structures not only provide mechanical support, but also promote cellular infiltration and vascular ingrowth from the surrounding host tissue, leading to a vascularised wound bed for the final coverage with STSG (Awad et al., 2000) after 3 weeks.
Experimental studies indicate that the incorporation of dermal substitutes is improved by the seeding with mesenchymal stem cells, keratinocytes and adipose tissue-derived microvascular fragments (ad-MVF) (Wisser and Steffes, 2003; Trottier et al., 2008; Frueh et al., 2017a) . Of interest, ad-MVF can be isolated in large amounts from fat tissue within a short time and represent fully functional vessel segments (Frueh et al., 2017b) . Hence, they bear the major advantage that their reassembly into new microvascular networks induces a rapid implant vascularisation and blood perfusion (Laschke et al., 2012; Laschke and Menger, 2015) . For this purpose, angiogenic sprouts, growing out of the vessel www.ecmjournal.org T Später et al. ad-MVF density affects implant vascularisation segments, have to develop interconnections (Nunes et al., 2010) . Since the growth rate of such angiogenic sprouts is ~5 µm/h (Utzinger et al., 2015) , the distance between individual ad-MVF crucially determines the kinetics of this network formation process (Später et al., 2017) . These considerations suggest that a high seeding density of ad-MVF markedly contributes to the success of this vascularisation strategy. On the other hand, it should be noted that, particularly in case of large tissue defects, this would require large volumes of donor fat tissue, which may not always be available under clinical conditions. Taking this into account, the aim of the present experimental study was to determine the lowest ad-MVF density needed to develop a sufficient vascularisation and incorporation of seeded implants. For this purpose, we performed an in-depth analysis to assess the number of ad-MVF that can be isolated from 1 mL of epididymal fat tissue of donor mice in dependency of their age. In addition, collagen-glycosaminoglycan matrices (Integra ® ) were seeded with three different ad-MVF densities and subsequently implanted into fullthickness skin defects within mouse dorsal skinfold chambers. Their vascularisation and incorporation was analysed throughout a 2-week observation period using intravital fluorescence microscopy, ultrasound and photoacoustic imaging, histology and immunohistochemistry.
Materials and Methods

Animals
All animal experiments were approved by the local governmental animal care committee (permit number: 33/2016) and conducted in accordance with the European legislation on the protection of animals (Directive 2010/63/EU) and the National Institutes of Health (NIH) guidelines on the care and use of laboratory animals (NIH publication #85-23 Rev. 1985) .
Dorsal skinfold chambers were implanted in wild-type C57BL/6 mice (Institute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany), with an age of 4-6 months and a body weight of 24-28 g. Epididymal fat was isolated from male green fluorescent protein (GFP) + mice [C57BL/6-Tg(CAG-EGFP)1Osb/J; The Jackson Laboratory, Bar Harbor, ME, USA], with an age of 7-12 months and a body weight of > 30 g, to guarantee large epididymal fat pads containing sufficient amounts of ad-MVF for the seeding of the matrices (Grässer et al., 2016) . The animals were housed under a 12 h light/dark cycle and received ad libitum water and standard food pellets (Altromin, Lage, Germany).
Isolation of ad-MVF
Ad-MVF were isolated from epididymal fat pads of GFP + donor mice, as previously described in detail (Frueh et al., 2017b) . Briefly, the bilateral epididymal fat pads were transferred into 10 % Dulbecco's modified eagle medium (DMEM; 100 U/mL penicillin, 0.1 mg/mL streptomycin; Biochrom, Berlin, Germany) and washed thrice with phosphate-buffered saline (PBS). Next, the isolated fat tissue was minced and digested for 10 min with collagenase NB4G (0.5 U/ mL; Serva, Heidelberg, Germany) under slow stirring and humidified atmospheric conditions (37 °C, 5 % CO 2 ). The digestion was neutralised with PBS supplemented with 20 % foetal calf serum (FCS) and the cell-vessel suspension was incubated at 37 °C for 5 min. The fat supernatant was removed, the remaining suspension was filtered through a 500 µm mesh and the GFP + ad-MVF were enriched up to a pellet size by a 5 min centrifugation at 120 ×g. Subsequently, this ad-MVF pellet was either used for in vitro analyses or resuspended in 1 µL of 0.9 % NaCl for the seeding of the implants.
Quantification and length distribution of isolated ad-MVF Donor mice for the isolation of ad-MVF were assigned to 6 age groups (7, 8, 9, 10, 11 and 12 months old) . To correlate the parameters animal age, fat tissue volume and ad-MVF number and size, ad-MVF were isolated from the epididymal fat pads of 18 donor mice (n = 3 per group). After isolation, 10 % of the total cell-vessel suspension was diluted 1 : 10 in PBS and 100 µL of this dilution were transferred into a 96-well plate to assess the number of ad-MVF by means of microscopic counting (Fig. 1a,b) . The total number of ad-MVF was subsequently extrapolated to the whole isolate (Frueh et al., 2017b) . Furthermore, the average ad-MVF length was measured by means of microscopic analysis.
Flow cytometry
To analyse the cellular composition of ad-MVF from 6 donor age groups (7, 8, 9, 10, 11 and 12 months old) by means of flow cytometry, ad-MVF, isolated from 18 male C57BL/6 mice (n = 3 per group), were digested for 30 min in Accutase ® (BioLegend, Fell, Germany) to single cells. Then, the single cells were analysed for the expression of the monoclonal rat anti-mouse endothelial cell marker CD31-phycoerythrin (PE) (BD Biosciences, Heidelberg, Germany), the perivascular cell marker mouse anti-α-smooth muscle actin (SMA) (Thermo Fisher Scientific Inc., Waltham, MA, USA), the monoclonal stromal/stem cell surface markers rat anti-mouse CD117-fluorescein isothiocyanate (FITC) (BD Biosciences), the mouse anti-rat/mouse CD90-FITC (BioLegend) and the hamster anti-rat/mouse CD29-FITC (BioLegend). Isotype identical rat IgG-PE or rat IgG-FITC (BD Biosciences), mouse IgG-FITC (BD Biosciences) and hamster IgG-FITC (BioLegend) served as controls. Additionally, cells were analysed for the expression of the purified polyclonal sheep anti-mouse/human adipocyte marker adipocytespecific adhesion molecule (ASAM) (R&D Systems, Wiesbaden, Germany), followed by a secondary donkey anti-sheep IgG-Alexa488 antibody (Molecular www.ecmjournal.org Probes, Eugene, OR, USA). Flow cytometric analyses were performed, using a FACScan (BD Biosciences) and data were assessed using the software package Cell-Quest Pro (BD Biosciences).
Seeding of Integra
®
A 4 mm biopsy punch (kaiEurope GmbH, Solingen, Germany) was used to cut 12.6 mm 2 identical implants out of a 1.3 mm thick Integra ® dermal regeneration template single layer without silicone sheet (Integra Life Sciences, Ratingen, Germany). The samples (Fig. 1c) were placed on a 500 µm cell strainer and 15 µL of 0.9 % NaCl, containing a high density (HD) of ~15,000 ad-MVF, a medium density (MD) of ~10,000 ad-MVF or a low density (LD) of ~5,000 ad-MVF (Fig. 1d) , were transferred onto the implants with a 20 µL pipette (Eppendorf, Wesseling-Berzdorf, Germany). Noteworthy, the used ad-MVF seeding density of the HD group was identical to that applied in previous studies (Frueh et al., 2017a) .
Modified dorsal skinfold chamber model
According to Sorg et al. (2007; 2009) , a modified dorsal skinfold chamber model was used for the in vivo analysis of ad-MVF-seeded implants (Fig. 1e) . For the implantation of the dorsal skinfold chamber (Irola Industriekomponenten GmbH & Co. KG, Schonach, Germany), the mice were anaesthetised by intraperitoneal injection of ketamine (75 mg/kg body weight; Ursotamin ® ; Serumwerke Bernburg, Bernburg, Germany) and xylazine (15 mg/kg body weight; Rompun ® ; Bayer, Leverkusen, Germany). The samples were seeded with a high density (HD), medium density (MD) and low density (LD) of ad-MVF. (e) C57BL/6 mouse with a dorsal skinfold chamber. Scale bar: 12 mm. (f) Schematic cross-section of a dorsal skinfold chamber preparation with a full-thickness skin defect filled with ad-MVF-seeded Integra ® (implant). The observation window provided direct access to the implant for repetitive intravital fluorescence microscopy, whereas ultrasound and photoacoustic imaging was performed from the backside of the chamber, which was covered with a PVC mask to prevent noise signal originating from the titanium frame. (g,h) Backside titanium frame of the chamber covered with a PVC mask (arrows = gaps for screws of the titanium frame; asterisk = opening for photoacoustic imaging). Scale bars: g = 10 mm, h = 6 mm.
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Then, the two symmetrical titanium frames were fixed on the extended dorsal skinfold, as described previously in detail . After a 48 h recovery period, the mice were anaesthetised again and a 4 mm full-thickness skin defect was created within the observation window of the chamber using a dermal biopsy punch (kaiEurope GmbH) and microsurgical instruments. Subsequently, the defect was filled with ad-MVFseeded Integra ® before the observation window of the chamber was sealed with a removable cover glass (Fig. 1f) .
Stereomicroscopy
To assess the epithelialisation of ad-MVF-seeded Integra ® , as well as the implant-induced degree of haemorrhage by planimetry, the anaesthetised animals were fixed on a Plexiglas ® stage and the dorsal skinfold chamber was positioned under a stereomicroscope (Leica M651, Wetzlar, Germany) on day 0 (day of implantation), 3, 6, 10 and 14. The chamber tissue was visualised in epi-illumination to identify epithelialised and non-epithelialised implant areas. Furthermore, trans-illumination was used to evaluate the extent of bleeding induced by implanted HD, MD and LD ad-MVF-seeded Integra ® (given in % of implant surface) by means of a semi-quantitative haemorrhagic score as follows: 1: no bleeding, 2: 1-25 %, 3: 26-50 %, 4: 51-75 %, 5: 76-100 %, 6: bleeding exceeding implant surface. The microscopic images were recorded by a DVD system and analysed using the CapImage computer-assisted off-line analysis system (Zeintl, Heidelberg, Germany). The epithelialised area (given in %) was calculated by the equation: (total implant area − non-epithelialised implant area) / (total implant area) × 100 (Später et al., 2016) .
Intravital fluorescence microscopy
After stereomicroscopy, 0.1 mL of the blood plasma marker FITC-labelled dextran (5 %; 150,000 Da; SigmaAldrich, Taufkirchen, Germany) was retrobulbarily injected into the venous plexus of the anaesthetised animals for contrast enhancement. The observation window of the chamber was positioned under a Zeiss Axiotech fluorescent microscope (Zeiss, Oberkochen, Germany) and the microscopic images were recorded by a charge-coupled device video camera (FK6990; Pieper, Schwerte, Germany) and a DVD system for off-line analyses (Laschke et al., 2015) .
The analysis of the microscopic images was performed using CapImage (Zeintl). The vascularisation of the implants was assessed in 12 regions of interest (ROIs). ROIs exhibiting red blood cell (RBC)-perfused microvessels were defined and counted as perfused ROIs (in % of all ROIs) (Später et al., 2017) . The functional microvessel density was determined as the total length of all RBC-perfused microvessels per ROI (cm/cm 2 ). In addition, the diameter (d, in µm) and centreline RBC velocity (v, µm/s) of 40 randomly selected microvessels were measured. Subsequently, these two parameters were used to calculate the wall shear rate (y, in s -1 ) by means of the Newtonian definition y = 8 × v/d (Ampofo et al., 2016) .
Ultrasound and photoacoustic imaging
Ultrasound and photoacoustic imaging was used to detect haemoglobin oxygen saturation (sO 2 ) in OxyHemo-mode within HD, MD and LD ad-MVFseeded Integra ® by using a Vevo LAZR system (FUJIFILM VisualSonics Inc., Toronto, ON, Canada) and a real-time microvisualisation LZ550 linear-array transducer (FUJIFILM VisualSonics Inc.) with a centre frequency of 40 MHz.
For in vitro analyses, freshly-seeded, nonimplanted Integra ® samples were embedded in ultrasound gel (Aquasonic 100; Parker, Fairfield, NJ, USA) to prevent interference with ultrasound coupling. For the in vivo analysis of implanted Integra ® on day 14, the chamber-equipped animals were anaesthetised with 1.5 % isofluorane in air and subsequently fixed in prone position on a heated stage. Heart rate and breathing rate were constantly monitored and the body temperature was maintained at 37 °C (THM100; Indus Instruments, Houston, TX, USA). To prevent noise signal originating from the titanium frames, the dorsal skinfold chamber was covered with a 3 mm soft polyvinyl chloride (PVC) mask ( Fig. 1g,h ; Sagustu International GmbH, Bruchmühlbach-Miesau, Germany) and the depilated skin, within the backside of the observation window, was covered with ultrasound gel to avoid air interference with ultrasound coupling into the animal.
For three-dimensional, high-resolution B-mode ultrasound and OxyHemo-mode photoacoustic image acquisition, the scanhead was driven by a linear motor to acquire two-dimensional images at regular spatial intervals, parallel and uniformly spaced at 150 μm intervals over the entire implant diameter. OxyHemo-mode photoacoustic images were taken at 750 nm and 850 nm with a two-dimensional gain of 34 dB (in vitro) and 32 dB (in vivo) to detect sO 2 within the samples (Mallidi et al., 2015; Rich and Seshadri, 2015) . All values were acquired using the Vevo LAB 1.7.2. software (FUJIFILM VisualSonics Inc.).
Experimental protocol
In a first set of experiments, the volume of the excised epididymal fat tissue from the 18 GFP + donor mice of the 6 different age groups (7, 8, 9, 10, 11 and 12 months old; n = 3 per group) was quantified. Subsequently, both the number of ad-MVF per mL fat tissue, as well as, the ad-MVF length were assessed by means of microscopic analysis. The cellular composition of ad-MVF after isolation was investigated by additional flow cytometric analyses.
For in vivo analyses, ad-MVF were harvested from the epididymal fat tissue of 8 GFP + donor mice. The isolated ad-MVF were divided into 3 different density groups (HD: ~15,000 ad-MVF; MD: ~10,000 www.ecmjournal.org ad-MVF; LD: ~5,000 ad-MVF) and subsequently seeded on Integra ® (n = 8 per group). The seeded matrices were implanted into full-thickness skin defects within dorsal skinfold chambers of 24 GFP -wild-type C57BL/6 recipient animals. Vascularisation, incorporation, epithelialisation and bleeding of the implants were analysed by means of repetitive stereomicroscopy and intravital fluorescence microscopy on day 0 (day of implantation), 3, 6, 10 and 14. Finally, ultrasound and photoacoustic imaging of 3 implants per group was performed on day 14. Thereafter, the animals were sacrificed with an overdose of anaesthesia and the dorsal skinfold chamber preparations were processed for histological and immunohistochemical analyses.
Histology and immunohistochemistry
Formalin-fixed samples of the dorsal skinfold preparations with the implants were embedded in paraffin and subsequently cut into 3 µm-thick sections. Haematoxylin and eosin (HE) staining of individual sections was performed according to standard procedures. In addition, the reddish appearance, under polarised light, of mature sirius red-stained collagen type I fibres was used to quantify the collagen content of implanted ad-MVF-seeded Integra ® . The collagen content was assessed in relation to normal skin in 4 central ROIs for each sample using a BX60 microscope (Olympus, Hamburg, Germany) and the imaging software cellSens Dimension 1.11 (Olympus) (Frueh et al., 2017a) .
Additional sections were co-stained using a monoclonal rat anti-mouse antibody against the endothelial cell marker CD31 (1 : 100; Dianova, Hamburg, Germany) and a polyclonal goat antibody against GFP (1 : 200; Rockland Immunochemicals, Limerick, PA, USA) while a goat anti-rat IgG Alexa555 (1 : 200; Life Technologies, Ober-Olm, Germany) and a biotinylated donkey anti-goat antibody (1 : 30; Dianova) served as secondary antibodies. The biotinylated antibody was detected by streptavidinAlexa488 (1 : 50; Life Technologies) and cell nuclei were stained with Hoechst 33342 (1 : 500; SigmaAldrich). The density of CD31 + microvessels (given in mm -2
) and the fraction of CD31 + /GFP + microvessels (given in %) were quantitatively analysed within the implants.
For the immunohistochemical detection of the cytokeratin + epithelial layer, covering the implanted Integra ® on day 14, sections of the largest crosssectional diameter of the matrices were incubated with a rabbit polyclonal anti-cytokeratin antibody (1 : 100; Abcam, Cambridge, UK), as primary antibody, followed by a biotinylated goat antirabbit IgG antibody (ready-to-use; Abcam). The biotinylated antibody was detected by peroxidaselabelled-streptavidin (1 : 50; Sigma-Aldrich) and 3,3-diaminobenzidine (Sigma-Aldrich) was used as chromogen. Using a BZ-8000 microscopic system (Keyence, Osaka, Japan), the length of the cytokeratin + epithelial layer and the diameter of the implants were measured to assess epithelialisation as: length 
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of cytokeratin + epithelial layer / total diameter of implant × 100.
For the immunohistochemical detection of myeloperoxidase (MPO) + neutrophilic granulocytes, CD68 + macrophages and CD3 + lymphocytes, sections were incubated with a rabbit polyclonal anti-MPO antibody (1 : 100; Abcam), a rabbit polyclonal anti-CD68 antibody (1 : 50; Abcam) and a rabbit polyclonal anti-CD3 antibody (1 : 100; Abcam), as primary antibodies, followed by a biotinylated goat anti-rabbit IgG antibody (ready-to-use; Abcam). The biotinylated antibody was detected by peroxidase-labelledstreptavidin (1 : 50; Sigma-Aldrich). 3-Amino-9-ethylcarbazole (Abcam) was used as chromogen. The sections were counterstained with Mayer's haemalum (Merck, Darmstadt, Germany) and the number of immune cells (given in mm -2 ) was quantitatively assessed in 6 ROIs per section by light microscopy (BX60).
Statistical analysis
After testing the data for normal distribution and equal variance, differences between the groups were analysed by ANOVA followed by the StudentNewman-Keuls post hoc test. In case of non-parametric data, differences were assessed by ANOVA on Ranks, followed by the Dunn's post hoc test (SigmaPlot 11.0; Jandel Corporation, San Rafael, CA, USA). All values were expressed as mean ± standard error of the mean (SEM). Statistical significance was accepted for a value of p < 0.05.
Results
Quantification, length distribution and cellular composition of ad-MVF
There were no significant differences in the available volume of epididymal adipose tissue from donor mice in the age range of 7-12 months (Fig. 2a) . In all analysed groups, ~1.4 mL adipose tissue could be harvested for the subsequent isolation of ad-MVF. From this amount of tissue, an overall number of ~40,000 ad-MVF per mL with an average length of ~40 µm could be enzymatically isolated (Fig. 2b,c) . More detailed analyses revealed that 73 % of the isolated ad-MVF from all 6 age groups exhibited a length of 21-50 µm (Fig. 2d) . Additional flow cytometric analyses showed a comparable cellular composition of ad-MVF from the donor animals of the different ages (Table 1) . Ad-MVF typically contained ~25 % CD31 + endothelial cells, ~17 % α-SMA + perivascular cells, ~ 8 % ASAM + adipocytes, as well as, ~51 %, ~8 % and ~8 % cells expressing the stromal/stem cell surface markers CD29, CD90 and CD117, respectively (Table 1) .
Vascularisation of ad-MVF-seeded implants
To analyse the in vivo vascularisation of HD, MD and LD ad-MVF-seeded Integra ® , a modified dorsal skinfold chamber model was used. This allowed for the repetitive visualisation and quantitative analysis of microvascular network formation by means of intravital fluorescence microscopy ( Fig.  3a-i) . The analyses revealed that the seeded ad-MVF were capable of developing interconnections with the surrounding host microvasculature of the fullthickness skin defects. This resulted in the onset of blood perfusion within the implanted matrices on day 6 (Fig. 3j) . Throughout the following observation period, the density of perfused microvessels progressively increased (Fig. 3k) . This was associated with typical signs of vascular maturation and remodelling, i.e. decrease of diameters, as well as, increase of centreline RBC velocities and wall shear rates of individual microvessels (Table 2) . Of interest, this vascularisation process was comparable in the groups of HD and MD ad-MVF-seeded Integra ® without significant differences in all measured morphological and microhaemodynamic parameters ( Fig. 3j,k ; Table 2 ). In contrast, LD ad-MVF-seeded matrices exhibited a reduced vascularisation with a lower number of perfused ROIs and functional microvessel density between day 6 and 14 after implantation (Fig. 3j,k) .
Of interest, the vascularisation process also included haemorrhagic bleeding within the implants (Fig. 4a-g ), which correlated with the extent of vascularisation and could be particularly observed during the phase of microvascular network development. Accordingly, HD and MD ad-MVFseeded Integra ® exhibited elevated haemorrhagic scores on day 6 and 10, when compared to LD ad-MVF-seeded implants (Fig. 4g) .
30.0 ± 1.8 16.1 ± 1.4 9.1 ± 0.9 48.3 ± 3.6 9.1 ± 1.0 7.9 ± 0.6 8 27.4 ± 1.6 19.8 ± 1.8 5.1 ± 0.3 51.0 ± 2.5 7.2 ± 1.1 6.4 ± 1.1 9 25.7 ± 0.9 15.5 ± 1.6 7.8 ± 1.0 50.3 ± 3.7 7.1 ± 0.5 7.2 ± 0.6 10 23.9 ± 5.1 14.8 ± 2.5 9.7 ± 1.7 57.7 ± 2.8 9.8 ± 1.4 10.8 ± 1.5 11 20.8 ± 0.5 16.4 ± 2.1 8.4 ± 0.5 44.9 ± 5.1 8.0 ± 0.8 6.9 ± 0.7 12 24.7 ± 4.7 20.1 ± 1.7 6.6 ± 1.7 51.2 ± 7.4 7.9 ± 1.2 8.6 ± 1.9 Table 1 . Cellular expression (%) of CD31, α-SMA, ASAM, CD29, CD90 and CD117 in ad-MVF isolated from the epididymal fat pads of 7-12 months old GFP + donor mice (n = 3 per group), as assessed by flow cytometric analysis. Results are shown as mean ± SEM. www.ecmjournal.org www.ecmjournal.org Table 2 . Diameter (µm), centreline RBC velocity (µm/s) and wall shear rate (s -1 ) of microvessels in HD (n = 8), MD (n = 8) and LD (n = 8) ad-MVF-seeded Integra ® , as assessed by intravital fluorescence microscopy and computer-assisted image analysis. Results are shown as mean ± SEM. In addition, ad-MVF-seeded matrices were analysed by means of ultrasound and photoacoustic imaging, which allowed for the evaluation of the samples' oxygenation. In line with the different seeding densities, sO 2 levels were highest in freshly HD ad-MVF-seeded, non-implanted matrices (Fig.  5a-g ). After the 14 d vascularisation period within the dorsal skinfold chamber model, LD ad-MVF-seeded Integra ® exhibited significantly lower sO 2 levels when compared to HD ad-MVF-seeded samples (Fig. 5h-n) . Noteworthy, there were no significant differences between HD and MD ad-MVF-seeded implants (Fig.  5n) .
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Incorporation and immune cell infiltration of ad-
MVF-seeded implants
At the end of the 14 d observation period, histological and immunohistochemical analyses were performed to study the incorporation of the ad-MVF-seeded implants. HE-stained sections of LD ad-MVF-seeded Integra ® exhibited a dense vascularised granulation tissue within the border zones, whereas the centre of the implants only contained a few single cells (Fig. 6e,f) . In contrast, in HD and MD ad-MVFseeded implants a dense tissue infiltration could not exclusively be observed in the border but also in the centre zones (Fig. 6a-d) . The analysis of sirius redstained sections revealed that LD ad-MVF-seeded Integra ® contained significantly less collagen fibres when compared to HD and MD ad-MVF-seeded samples (Fig. 6g-k) . Taken together, these findings indicated an insufficient incorporation of LD ad-MVF-seeded implants into the surrounding host tissue.
In line with our intravital fluorescent microscopic results, the density of CD31 + microvessels was significantly lower in LD ad-MVF-seeded Integra ® when compared to HD and MD ad-MVF-seeded matrices (Fig. 6l-o) . Of interest, CD31 + /GFP + costaining on day 14 demonstrated that ~90 % of all detected microvessels in HD, MD and LD ad-MVFseeded implants originated from GFP + ad-MVF ( Fig.  6p-s) . Additional immunohistochemical stainings revealed that the implants were infiltrated with MPO + neutrophilic granulocytes, CD68 + macrophages and, to a smaller extent, CD3
+ lymphocytes (Fig. 7a-l ). In accordance with their overall reduced cellular infiltration, LD ad-MVF-seeded matrices contained significantly smaller numbers of these immune cell subpopulations when compared to the HD and MD ad-MVF-seeded implants (Fig. 7j-l) .
Epithelialisation of the ad-MVF-seeded implants
The continuous access to the ad-MVF-seeded matrices through the observation window of the dorsal skinfold chamber allowed for the repetitive stereomicroscopic analysis of implant epithelialisation (Fig. 8a-f ). HD and MD ad-MVF-seeded Integra ® exhibited a comparable epithelialisation over time while the epithelialised surface of LD ad-MVF-seeded Integra ® was significantly less on days 10 and 14 (Fig. 8g) . Immunohistochemical analyses on day 14 confirmed these findings. Only ~57 % of LD ad-MVF-seeded Integra ® were covered with a cytokeratin + epithelial layer, whereas the cytokeratin + epithelial coverage of HD and MD ad-MVF-seeded implants was ~75 % (Fig. 8h-k) .
Discussion
Autologous STSG is the gold standard for the coverage of excised burn wounds (Supp et al., 2005; Kneilling et al., 2011; Kanapathy et al., 2016) . For this purpose, a well-vascularised wound bed is an indispensable requirement (Schultz et al., 2003) . In a promising experimental approach, we could recently demonstrate that this can be achieved by the implantation of ad-MVF-seeded dermal substitutes, which induce the formation of new microvascular networks at the defect site (Frueh et al., 2017a) . In fact, seeding of ~120,000 ad-MVF/cm² Integra ® , www.ecmjournal.org 5. (a,c,e) B-mode ultrasound and (b,d,f) OxyHemo-mode photoacoustic imaging of (a,b) HD,(c,d) MD and (e,f) LD ad-MVF-seeded Integra ® directly after the seeding procedure (b,d,f; red areas = high oxygenation, blue areas = low oxygenation). Scale bars: 600 µm. (g) sO 2 (%) within freshly HD (black bar, n = 3), MD (grey bar, n = 3) and LD (white bar, n = 3) ad-MVF-seeded Integra ® . Means ± SEM. (h,j,l) B-mode ultrasound and (i,k,m) OxyHemo-mode photoacoustic imaging of (h,i) HD, (j,k) MD and (l,m) LD ad-MVF-seeded Integra ® on day 14 after implantation into full-thickness skin defects within dorsal skinfold chambers of C57BL/6 mice (l,k,m; red areas = high oxygenation, blue areas = low oxygenation). Scale bars: 600 µm. (n) sO 2 (%) within HD (black bar, n = 3), MD (grey bar, n = 3) and LD (white bar, n = 3) ad-MVF-seeded Integra ® on day 14 after implantation. Means ± SEM. * p < 0.05 vs. HD ad-MVF-seeded Integra ® .
www.ecmjournal.org T Später et al. ad-MVF density affects implant vascularisation corresponding to the HD ad-MVF-seeded group of the present study, resulted in a rapid vascularisation and incorporation of the matrix after implantation into full-thickness skin defects (Frueh et al., 2017a) . However, particularly in case of massive burn injuries affecting large surface areas of the body (Supp et al., 2005) , the available amount of donor fat tissue for the isolation of ad-MVF may be limited. Taking this into account, our novel results demonstrated that a markedly reduced number of ~80,000 ad-MVF/cm² Integra ® , corresponding to the MD ad-MVF-seeded group, still allowed for a sufficient vascularisation and incorporation of the dermal substitute. In contrast, reducing the number to 40,000 ad-MVF/cm² Integra ® , corresponding to the LD ad-MVF-seeded group, resulted in an insufficient vascularisation and incorporation, as indicated by the lack of a dense vascularised granulation tissue in the centre of the substitute.
To guarantee the seeding of Integra ® with welldefined ad-MVF densities, we first clarified whether individual mice markedly differ in terms of the amount of available epididymal adipose tissue and ad-MVF. We found that there were no significant differences between donor animals in the age range of 7-12 months. In addition, the isolated ad-MVF had a comparable average length and cellular composition. Of interest, the ad-MVF did not only contain CD31 + endothelial cells and α-SMA + perivascular cells, but also cells expressing the stem cell surface markers CD90 and CD117, which have been reported to exhibit a high regenerative and angiogenic potential (Li et al., 2003; Li et al., 2005; Oishi and Ito-Dufros, 2006) .
Ad-MVF seeded matrices were implanted into fullthickness skin defects within modified dorsal skinfold chambers. This approach provided deep insights into the vascularisation and incorporation process of the implants by combining sophisticated, noninvasive in vivo imaging technologies with additional histological and immunohistochemical analyses. Using intravital fluorescence microscopy, we found that HD and MD ad-MVF-seeded Integra ® exhibited a comparable vascularisation over time, whereas LD ad-MVF-seeded implants were characterised by a significantly lower number of perfused ROIs and functional microvessel density. In line with these findings, additional photoacoustic measurements (Später et al., 2017) . This process not only involves the interconnection of individual ad-MVF with each other but also the development of anastomoses with the surrounding vessels of the host tissue. The latter mechanism results in the early onset of blood perfusion, while the newly forming microvascular networks within the ad-MVF-seeded implants have not been fully established yet and, thus, are characterised by an increased leakage of blood. In line with this view, the formation of haemorrhages within the implants of all three groups was most pronounced between day 6 and 10. Moreover, the delayed onset of blood perfusion in LD ad-MVF-seeded matrices was associated with less bleedings on day 6. On day 14, the extent of haemorrhages decreased again. This can be explained by a progressive stabilisation and maturation of the microvascular networks, as indicated by decreased diameters, as well as, increased centreline RBC velocities and wall shear rates of individual microvessels over time .
Additional immunohistochemical analyses on day 14 showed that the pores of the centre of both HD and MD ad-MVF-seeded implants were filled with a vascularised granulation tissue, whereas the LD ad-MVF-seeded matrices mainly contained infiltrating single cells. As expected, LD ad-MVF-seeded implants also exhibited a significantly lower density of CD31 + microvessels. However, the fraction of GFP as assessed by immunohistochemical analysis on day 14 after implantation. Means ± SEM. www.ecmjournal.org microvessels was comparably high in all three groups. This proves that, even in the poorly vascularised LD ad-MVF-seeded implants, the vessel segments survived throughout the 14 d implantation period. On the other hand, this finding shows that less GFP -microvessels of the surrounding host tissue invaded the matrices of this group. This positive correlation between a low ad-MVF seeding density and a reduced ingrowth of blood vessels may be explained by decreased levels of pro-angiogenic growth factors, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), within the implants. In fact, isolated ad-MVF have previously been shown to release relevant amounts of these factors, which may markedly contribute to their high angiogenic activity after in vivo implantation (Laschke et al., 2012) . In this context, it should be considered that there is also a close link between angiogenesis and inflammation (Fiedler et al., 2006; DiPietro, 2016) . Several studies have reported that pro-angiogenic factors can act as chemokines for the recruitment of immune cells (Khoury and Ziyadeh, 2011; Barbay et al., 2015) . Accordingly, we detected relatively large numbers of MPO + neutrophilic granulocytes, CD68 + macrophages and CD3 + lymphocytes in HD and MD ad-MVF-seeded Integra ® . Since immune cell infiltration is a key event in wound healing (Reinke and Sorg, 2012) and adequate biomaterial integration (Anderson et al., 2008) , this may have further contributed to the improved incorporation of HD and MD ad-MVF-seeded implants, which finally exhibited a higher collagen content and increased surface epithelialisation, when compared to LD ad-MVF-seeded Integra ® .
Conclusions
This study demonstrates that a reduction from 120,000 to 80,000 ad-MVF/cm² Integra ® does not affect the implant's vascularisation and incorporation. These novel findings underline the high vascularisation potential of ad-MVF and indicate that 33 % less adipose tissue is required for the isolation of ad-MVF needed for a rapid and sufficient vascularisation of the implanted Integra ® . Under clinical conditions, this may be particularly relevant for the treatment of patients with extensive skin defects and/or limited availability of fat tissue.
